Skip to main content
. 2021 Dec 16;20:236. doi: 10.1186/s12933-021-01430-3

Fig. 2.

Fig. 2

Forest plots examining the kidney outcome in participants of ten CVOTs irrespective of the presence of type 2 diabetes and diabetic kidney disease. There is a moderate and borderline significant heterogeneity in the analysis (I2 = 35%, P = 0.10)